| NDC | 47781-384-26 |
| Set ID | 82df3237-636b-7bf9-3ba0-2b476e74bf4c |
| Category | HUMAN PRESCRIPTION DRUG LABEL |
| Packager | Alvogen Inc. |
| Generic Name | |
| Product Class | |
| Product Number | |
| Application Number | ANDA208823 |
![OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSION (OSELTAMIVIR PHOSPHATE) POWDER, FOR SUSPENSION [ALVOGEN INC.]](https://medic.hrt.org//dailymed/images/7169/carton.jpg)
![OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSION (OSELTAMIVIR PHOSPHATE) POWDER, FOR SUSPENSION [ALVOGEN INC.]](https://medic.hrt.org//dailymed/images/7169/label.jpg)
![OSELTAMIVIR PHOSPHATE FOR ORAL SUSPENSION (OSELTAMIVIR PHOSPHATE) POWDER, FOR SUSPENSION [ALVOGEN INC.]](https://medic.hrt.org//dailymed/images/7169/structure.jpg)
| NDC | 47781-384-26 |
| Set ID | 82df3237-636b-7bf9-3ba0-2b476e74bf4c |
| Category | HUMAN PRESCRIPTION DRUG LABEL |
| Packager | Alvogen Inc. |
| Generic Name | |
| Product Class | |
| Product Number | |
| Application Number | ANDA208823 |